Could beta-blockers precede or replace angiotensin-converting enzyme inhibitors in heart failure?
Remme
Willem J
WJ
Sticares Cardiovascular Research Foundation, Rhoon, The Netherlands. w.j.remme@sticares.org <w.j.remme@sticares.org>
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D002227:Carbazoles / Q000627:therapeutic use; D000077261:Carvedilol; D004341:Drug Evaluation; D019317:Evidence-Based Medicine / Q000379:methods; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D011412:Propanolamines / Q000627:therapeutic use; D016896:Treatment Outcome; D020257:Ventricular Remodeling / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D002227:Carbazoles; D011412:Propanolamines; D000077261:Carvedilol